Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Martha Lacy
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Concepts & Ideas
Physiology
Anatomy
Chemicals & Drugs
Sign-in to see full Profile
Network (preview)
144
Gertz, Morie
119
Dispenzieri, Angela
75
Greipp, Philip
73
Kyle, Robert
68
Rajkumar, Vincent
61
Witzig, Thomas
59
Lust, John
54
Fonseca, Rafael
50
Litzow, Mark
47
Hayman, Suzanne
40
Gastineau, Dennis
39
Kumar, Shaji
28
Inwards, David
26
Tefferi, Ayalew
21
Dingli, David
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Martha Lacy (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Lacy Martha Q; Jacobus Susanna; Blood Emily A; Kay Neil E; Rajkumar S Vincent; Greipp Philip R
Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): a trial of the Eastern Cooperative Oncology Group.
Leukemia research 2009;33(11):1485-9.
-
2009: Lacy Martha Q; Hayman Suzanne R; Gertz Morie A; Dispenzieri Angela; Buadi Francis; Kumar Shaji; Greipp Philip R; Lust John A; Russell Stephen J; Dingli David; Kyle Robert A; Fonseca Rafael; Bergsagel P Leif; Roy Vivek; Mikhael Joseph R; Stewart A Keith; Laumann Kristina; Allred Jacob B; Mandrekar Sumithra J; Rajkumar S Vincent
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(30):5008-14.
-
2009: Gertz Morie A; Leung Nelson; Lacy Martha Q; Dispenzieri Angela; Zeldenrust Steven R; Hayman Suzanne R; Buadi Francis K; Dingli David; Greipp Philip R; Kumar Shaji K; Lust John A; Rajkumar S Vincent; Russell Stephen J; Witzig Thomas E
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(10):3132-7.
-
2009: Kapoor Prashant; Kumar Shaji; Fonseca Rafael; Lacy Martha Q; Witzig Thomas E; Hayman Suzanne R; Dispenzieri Angela; Buadi Francis; Bergsagel P Leif; Gertz Morie A; Dalton Robert J; Mikhael Joseph R; Dingli David; Reeder Craig B; Lust John A; Russell Stephen J; Roy Vivek; Zeldenrust Steven R; Stewart A Keith; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone.
Blood 2009;114(3):518-21.
-
2009: Costa Luciano J; Kumar Shaji; Dispenzieri Angela; Hayman Suzanne E; Buadi Francis K; Dingli David; Litzow Mark R; Gertz Morie A; Lacy Martha Q
Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
Leukemia & lymphoma 2009;50(5):781-7.
-
2009: Gertz M A; Kumar S K; Lacy M Q; Dispenzieri A; Hayman S R; Buadi F K; Dingli D; Gastineau D A; Winters J L; Litzow M R
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.
Bone marrow transplantation 2009;43(8):619-25.
-
2009: Lust John A; Lacy Martha Q; Zeldenrust Steven R; Dispenzieri Angela; Gertz Morie A; Witzig Thomas E; Kumar Shaji; Hayman Suzanne R; Russell Stephen J; Buadi Francis K; Geyer Susan M; Campbell Megan E; Kyle Robert A; Rajkumar S Vincent; Greipp Philip R; Kline Michael P; Xiong Yuning; Moon-Tasson Laurie L; Donovan Kathleen A
Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.
Mayo Clinic proceedings. Mayo Clinic 2009;84(2):114-22.
-
2009: Leung N; Gloor J M; Dean P G; Lacy M Q; Porrata L F; Griffin M D
Acute cellular rejection in a renal allograft immediately following leukocyte engraftment after auto-SCT.
Bone marrow transplantation 2009;43(4):345-6.
-
2008: Gertz Morie A; Ansell Stephen M; Dingli David; Dispenzieri Angela; Buadi Francis K; Elliott Michelle A; Gastineau Dennis A; Hayman Suzanne R; Hogan William J; Inwards David J; Johnston Patrick B; Kumar Shaji; Lacy Martha Q; Leung Nelson; Micallef Ivana N M; Porrata Luis F; Schafer Barbara A; Wolf Robert C; Litzow Mark R
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative.
Mayo Clinic proceedings. Mayo Clinic 2008;83(10):1131-8.
-
2008: Kumar Shaji; Pérez Waleska S; Zhang Mei-Jie; Ballen Karen; Bashey Asad; To L Bik; Bredeson Christopher N; Cairo Mitchell S; Elfenbein Gerald J; Freytes César O; Gale Robert Peter; Gibson John; Kyle Robert A; Lacy Martha Q; Lazarus Hillard M; McCarthy Philip L; Milone Gustavo A; Moreb Jan S; Pavlovsky Santiago; Reece Donna E; Vesole David H; Wiernik Peter H; Hari Parameswaran
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(10):1134-40.
-
2008: Costa L J; Rodriguez V; Porrata L F; Lacy M Q; Elliott M A; Gertz M A; Gastineau D A; Litzow M R
Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
Bone marrow transplantation 2008;42(7):497-8.
-
2008: Malhotra Pankaj; Hogan William J; Litzow Mark R; Elliott Michelle A; Gastineau Dennis A; Ansell Stephen M; Dispenzieri Angela; Gertz Morie A; Hayman Suzanne R; Inwards David J; Lacy Martha Q; Micallef Ivana N; Porrata Luis F; Tefferi Ayalew
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years.
Leukemia & lymphoma 2008;49(9):1724-30.
-
2008: Gertz Morie A; Lacy Martha Q; Lust John A; Greipp Philip R; Witzig Thomas E; Kyle Robert A
Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis.
Haematologica 2008;93(9):1402-6.
-
2008: Kumar S; Mahmood S T; Lacy M Q; Dispenzieri A; Hayman S R; Buadi F K; Dingli D; Rajkumar S V; Litzow M R; Gertz M A
Impact of early relapse after auto-SCT for multiple myeloma.
Bone marrow transplantation 2008;42(6):413-20.
-
2008: Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji; Kyle Robert A; Rajkumar S Vincent; Edwards Brooks S; Rodeheffer Richard J; Frantz Robert P; Kushwaha Sudhir S; Clavell Alfredo L; Dearani Joseph A; Sundt Thoralf M; Daly Richard C; McGregor Christopher G A; Gastineau Dennis A; Litzow Mark R; Gertz Morie A
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2008;27(8):823-9.
-
2008: Kumar Shaji K; Dingli David; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Buadi Francis K; Rajkumar S Vincent; Litzow Mark R; Gertz Morie A
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis.
American journal of hematology 2008;83(8):614-7.
-
2008: Lacy Martha Q; Alsina Melissa; Fonseca Rafael; Paccagnella M Luisa; Melvin Carrie L; Yin Donghua; Sharma Amarnath; Enriquez Sarano M; Pollak Michael; Jagannath Sundar; Richardson Paul; Gualberto Antonio
Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 Receptor monoclonal antibody CP-751,871 in patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3196-203.
-
2008: Ege Hilmi; Gertz Morie A; Markovic Svetomir N; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji K; Porrata Luis F
Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study.
British journal of haematology 2008;141(6):792-8.
-
2008: Leung N; Gertz M A; Zeldenrust S R; Rajkumar S V; Dispenzieri A; Fervenza F C; Kumar S; Lacy M Q; Lust J A; Greipp P R; Witzig T E; Hayman S R; Russell S J; Kyle R A; Winters J L
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.
Kidney international 2008;73(11):1282-8.
-
2008: Kumar S K; Dingli D; Dispenzieri A; Lacy M Q; Hayman S R; Buadi F K; Rajkumar S V; Litzow M R; Gertz M A
Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT.
Bone marrow transplantation 2008;41(12):1013-9.
-
2008: Lorenz Elizabeth C; Gertz Morie A; Fervenza Fernando C; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Gastineau Dennis A; Leung Nelson
Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(6):2052-7.
-
2008: Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Kumar Shaji K; Buadi Francis; Dingli David; Litzow Mark R; Gastineau Dennis A; Inwards David J; Elliott Michelle A; Micallef Ivana N; Ansell Stephen M; Hogan William J; Porrata Luis F; Johnston Patrick A; Afessa Bekele; Bryce Alan; Kyle Robert A; Gertz Morie A
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.
European journal of haematology 2008;80(5):397-406.
-
2008: Tiedemann R E; Gonzalez-Paz N; Kyle R A; Santana-Davila R; Price-Troska T; Van Wier S A; Chng W J; Ketterling R P; Gertz M A; Henderson K; Greipp P R; Dispenzieri A; Lacy M Q; Rajkumar S V; Bergsagel P L; Stewart A K; Fonseca R
Genetic aberrations and survival in plasma cell leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(5):1044-52.
-
2008: Bellavia Diego; Pellikka Patricia A; Abraham Theodore P; Al-Zahrani Ghormallah B; Dispenzieri Angela; Oh Jae K; Bailey Kent R; Wood Christina M; Lacy Martha Q; Miyazaki Chinami; Miller Fletcher A
Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography.
The American journal of cardiology 2008;101(7):1039-45.
-
2008: Kumar Shaji K; Dingli David; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Buadi Francis K; Rajkumar S Vincent; Litzow Mark R; Gertz Morie A
Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.
British journal of haematology 2008;141(2):205-11.
-
2008: Kumar Shaji; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Leung Nelson; Zeldenrust Steve R; Buadi Francis K; Kyle Robert A; Rajkumar S Vincent; Gertz Morie A
Serum uric acid: novel prognostic factor in primary systemic amyloidosis.
Mayo Clinic proceedings. Mayo Clinic 2008;83(3):297-303.
-
2008: Kumar Shaji K; Rajkumar S Vincent; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Buadi Francis K; Zeldenrust Steven R; Dingli David; Russell Stephen J; Lust John A; Greipp Philip R; Kyle Robert A; Gertz Morie A
Improved survival in multiple myeloma and the impact of novel therapies.
Blood 2008;111(5):2516-20.
-
2007: Dingli David; Pacheco Jorge M; Nowakowski Grzegorz S; Kumar Shaji K; Dispenzieri Angela; Hayman Suzanne R; Lacy Martha Q; Gastineau Dennis A; Gertz Morie A
Relationship between depth of response and outcome in multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4933-7.
-
2007: Gertz M A; Lacy M Q; Dispenzieri A; Hayman S R; Kumar S K; Leung N; Gastineau D A
Transplantation without growth factor: engraftment kinetics after stem cell transplantation for primary systemic amyloidosis (AL).
Bone marrow transplantation 2007;40(10):989-93.
-
2007: Rajkumar S Vincent; Richardson Paul G; Lacy Martha Q; Dispenzieri Angela; Greipp Philip R; Witzig Thomas E; Schlossman Robert; Sidor Carolyn F; Anderson Kenneth C; Gertz Morie A
Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6162-7.
-
2007: Lacy Martha Q; Gertz Morie A; Dispenzieri Angela; Hayman Suzanne R; Geyer Susan; Kabat Brian; Zeldenrust Steven R; Kumar Shaji; Greipp Philip R; Fonseca Rafael; Lust John A; Russell Stephen J; Kyle Robert A; Witzig Thomas E; Bergsagel P Leif; Stewart A Keith; Rajkumar S Vincent
Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma.
Mayo Clinic proceedings. Mayo Clinic 2007;82(10):1179-84.
-
2007: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji K; Leung Nelson; Gastineau Dennis A
Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response.
Haematologica 2007;92(10):1415-8.
-
2007: Kumar S; Dispenzieri A; Lacy M Q; Hayman S R; Buadi F K; Gastineau D A; Litzow M R; Fonseca R; Roy V; Rajkumar S V; Gertz M A
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(9):2035-42.
-
2007: Rajkumar S Vincent; Lacy Martha Q; Kyle Robert A
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Blood reviews 2007;21(5):255-65.
-
2007: Dingli David; Pacheco Jorge M; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji K; Lacy Martha Q; Gastineau Dennis A; Gertz Morie A
Serum M-spike and transplant outcome in patients with multiple myeloma.
Cancer science 2007;98(7):1035-40.
-
2007: Leung Nelson; Dispenzieri Angela; Lacy Martha Q; Kumar Shaji K; Hayman Suzanne R; Fervenza Fernando C; Cha Stephen S; Gertz Morie A
Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(3):440-4.
-
2007: Gertz M A; Lacy M Q; Dispenzieri A; Hayman S R; Kumar S; Leung N; Gastineau D A
Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma.
Bone marrow transplantation 2007;39(10):605-11.
-
2007: Dingli David; Pacheco Jorge M; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji K; Lacy Martha Q; Gastineau Dennis A; Gertz Morie A
In vivo and in silico studies on single versus multiple transplants for multiple myeloma.
Cancer science 2007;98(5):734-9.
-
2007: Hoyer Robert J; Leung Nelson; Witzig Thomas E; Lacy Martha Q
Treatment of diuretic refractory pleural effusions with bevacizumab in four patients with primary systemic amyloidosis.
American journal of hematology 2007;82(5):409-13.
-
2007: Dispenzieri Angela; Rajkumar S Vincent; Gertz Morie A; Fonseca Rafael; Lacy Martha Q; Bergsagel P Leif; Kyle Robert A; Greipp Philip R; Witzig Thomas E; Reeder Craig B; Lust John A; Russell Stephen J; Hayman Suzanne R; Roy Vivek; Kumar Shaji; Zeldenrust Steven R; Dalton Robert J; Stewart A Keith
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement.
Mayo Clinic proceedings. Mayo Clinic 2007;82(3):323-41.
-
2007: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji
Transplantation for amyloidosis.
Current opinion in oncology 2007;19(2):136-41.
-
2007: Stewart A K; Bergsagel P L; Greipp P R; Dispenzieri A; Gertz M A; Hayman S R; Kumar S; Lacy M Q; Lust J A; Russell S J; Witzig T E; Zeldenrust S R; Dingli D; Reeder C B; Roy V; Kyle R A; Rajkumar S V; Fonseca R
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(3):529-34.
-
2007: Ocio E M; Schop R F J; Gonzalez B; Van Wier S A; Hernandez-Rivas J M; Gutierrez N C; Garcia-Sanz R; Moro M J; Aguilera C; Hernandez J; Xu R; Greipp P R; Dispenzieri A; Jalal S M; Lacy M Q; Gonzalez-Paz N; Gertz M A; San Miguel J F; Fonseca R
6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis.
British journal of haematology 2007;136(1):80-6.
-
2007: Dispenzieri Angela; Lacy Martha Q; Zeldenrust Steven R; Hayman Suzanne R; Kumar Shaji K; Geyer Susan M; Lust John A; Allred Jacob B; Witzig Thomas E; Rajkumar S Vincent; Greipp Philip R; Russell Stephen J; Kabat Brian; Gertz Morie A
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis.
Blood 2007;109(2):465-70.
-
2006: Fonseca R; Van Wier S A; Chng W J; Ketterling R; Lacy M Q; Dispenzieri A; Bergsagel P L; Rajkumar S V; Greipp P R; Litzow M R; Price-Troska T; Henderson K J; Ahmann G J; Gertz M A
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(11):2034-40.
-
2006: Bryce Alan H; Dispenzieri Angela; Kyle Robert A; Lacy Martha Q; Rajkumar S Vincent; Inwards David J; Yasenchak Christopher A; Kumar Shaji K; Gertz Morie A
Response to rituximab in patients with type II cryoglobulinemia.
Clinical lymphoma & myeloma 2006;7(2):140-4.
-
2006: Schop Roelandt F J; Van Wier Scott A; Xu Ruifang; Ghobrial Irene; Ahmann Gregory J; Greipp Philip R; Kyle Robert A; Dispenzieri Angela; Lacy Martha Q; Rajkumar S Vincent; Gertz Morie A; Fonseca Rafael
6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
Cancer genetics and cytogenetics 2006;169(2):150-3.
-
2006: Kademani Deepak; Koka Sreenivas; Lacy Martha Q; Rajkumar S Vincent
Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy.
Mayo Clinic proceedings. Mayo Clinic 2006;81(8):1100-3.
-
2006: Lacy Martha Q; Dispenzieri Angela; Gertz Morie A; Greipp Philip R; Gollbach Kimberly L; Hayman Suzanne R; Kumar Shaji; Lust John A; Rajkumar S Vincent; Russell Stephen J; Witzig Thomas E; Zeldenrust Steven R; Dingli David; Bergsagel P Lief; Fonseca Rafael; Reeder Craig B; Stewart A Keith; Roy Vivek; Dalton Robert J; Carr Alan B; Kademani Deepak; Keller Eugene E; Viozzi Christopher F; Kyle Robert A
Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2006;81(8):1047-53.
-
2006: Lacy Martha Q
Multiple myeloma: new options, new challenges.
Mayo Clinic proceedings. Mayo Clinic 2006;81(7):877-9.
-
2006: Valente Maria; Roy Vivek; Lacy Martha Q; Dispenzieri Angela; Gertz Morie A
Autologous stem cell transplantation and IgM amyloidosis.
Leukemia & lymphoma 2006;47(6):1006-12.
-
2006: Buadi F K; Micallef I N; Ansell S M; Porrata L F; Dispenzieri A; Elliot M A; Gastineau D A; Gertz M A; Lacy M Q; Litzow M R; Tefferi A; Inwards D J
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma.
Bone marrow transplantation 2006;37(11):1017-22.
-
2006: Elliott M A; Tefferi A; Hogan W J; Letendre L; Gastineau D A; Ansell S M; Dispenzieri A; Gertz M A; Hayman S R; Inwards D J; Lacy M Q; Micallef I N; Porrata L F; Litzow M R
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia.
Bone marrow transplantation 2006;37(11):1003-8.
-
2006: Chng W J; Santana-Dávila R; Van Wier S A; Ahmann G J; Jalal S M; Bergsagel P L; Chesi M; Trendle M C; Jacobus S; Blood E; Oken M M; Henderson K; Kyle R A; Gertz M A; Lacy M Q; Dispenzieri A; Greipp P R; Fonseca R
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(5):807-13.
-
2006: Chng Wee J; Ahmann Greg J; Henderson Kim; Santana-Davila Rafael; Greipp Philip R; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Kumar Shaji; Rajkumar S Vincent; Lust John A; Kyle Robert A; Zeldenrust Steven R; Hayman Suzanne R; Fonseca Rafael
Clinical implication of centrosome amplification in plasma cell neoplasm.
Blood 2006;107(9):3669-75.
-
2006: Ghobrial Irene M; Fonseca Rafael; Gertz Morie A; Plevak Matthew F; Larson Dirk R; Therneau Terry M; Wolf Robert C; Hoffmann Randi J; Lust John A; Witzig Thomas E; Lacy Martha Q; Dispenzieri Angela; Vincent Rajkumar S; Zeldenrust Stephen R; Greipp Philip R; Kyle Robert A
Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia.
British journal of haematology 2006;133(2):158-64.
-
2006: Dispenzieri Angela; Lacy Martha Q; Katzmann Jerry A; Rajkumar S Vincent; Abraham Roshini S; Hayman Suzanne R; Kumar Shaji K; Clark Raynell; Kyle Robert A; Litzow Mark R; Inwards David J; Ansell Stephen M; Micallef Ivana M; Porrata Luis F; Elliott Michelle A; Johnston Patrick B; Greipp Philip R; Witzig Thomas E; Zeldenrust Steven R; Russell Stephen J; Gastineau Dennis; Gertz Morie A
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
Blood 2006;107(8):3378-83.
-
2006: Dingli David; Nowakowski Grzegorz S; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Rajkumar S Vincent; Greipp Philip R; Litzow Mark R; Gastineau Dennis A; Witzig Thomas E; Gertz Morie A
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system.
Blood 2006;107(8):3384-8.
-
2006: Halligan Christine S; Lacy Martha Q; Vincent Rajkumar S; Dispenzieri Angela; Witzig Thomas E; Lust John A; Fonseca Rafael; Gertz Morie A; Kyle Robert A; Pruthi Rajiv K
Natural history of thromboembolism in AL amyloidosis.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2006;13(1):31-6.
-
2006: Dingli David; Nowakowski Grzegorz S; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne; Litzow Mark R; Gastineau Dennis A; Gertz Morie A
Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myeloma.
Clinical lymphoma & myeloma 2006;6(5):384-8.
-
2006: Borson Nancy D; Lacy Martha Q; Wettstein Peter J
Expression of mRNA for a newly identified Pax5 exon is reduced in multiple myeloma.
Mammalian genome : official journal of the International Mammalian Genome Society 2006;17(3):248-56.
-
2006: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji K
High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
Expert review of anticancer therapy 2006;6(3):343-60.
-
2006: Dispenzieri Angela; Gertz Morie A; Lacy Martha Q; Geyer Susan M; Fitch Tom R; Fenton Robert G; Fonseca Rafael; Isham Crescent R; Ziesmer Steven C; Erlichman Charles; Bible Keith C
Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points.
Haematologica 2006;91(3):390-3.
-
2006: Chng W J; Winkler J M; Greipp P R; Jalal S M; Bergsagel P L; Chesi M; Trendle M C; Ahmann G J; Henderson K; Blood E; Oken M M; Hulbert A; Van Wier S A; Santana-Dávila R; Kyle R A; Gertz M A; Lacy M Q; Dispenzieri A; Fonseca R
Ploidy status rarely changes in myeloma patients at disease progression.
Leukemia research 2006;30(3):266-71.
-
2006: Xiong Yuning; Donovan Kathleen A; Kline Michael P; Gornet Michael K; Moon-Tasson Laurie L; Lacy Martha Q; Dispenzieri Angela; Gertz Morie A; Greipp Philip R; Lust John A
Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2006;26(2):83-95.
-
2006: Dispenzieri Angela; Gertz Morie A; Lacy Martha Q; Geyer Susan M; Greipp Phillip R; Rajkumar S Vincent; Kimlinger Teresa; Lust John A; Fonseca Rafael; Allred Jacob; Witzig Thomas E
A phase II trial of imatinib in patients with refractory/relapsed myeloma.
Leukemia & lymphoma 2006;47(1):39-42.
-
2005: Dingli David; Rajkumar S Vincent; Nowakowski Grzegorz S; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne; Fonseca Rafael; Lust John A; Kyle Robert A; Greipp Philip R; Witzig Thomas E
Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
Haematologica 2005;90(12):1650-4.
-
2005: Rajkumar S Vincent; Hayman Suzanne R; Lacy Martha Q; Dispenzieri Angela; Geyer Susan M; Kabat Brian; Zeldenrust Steven R; Kumar Shaji; Greipp Philip R; Fonseca Rafael; Lust John A; Russell Stephen J; Kyle Robert A; Witzig Thomas E; Gertz Morie A
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.
Blood 2005;106(13):4050-3.
-
2005: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R
Amyloidosis: diagnosis and management.
Clinical lymphoma & myeloma 2005;6(3):208-19.
-
2005: Leung Nelson; Leung Tessa R; Cha Stephen S; Dispenzieri Angela; Lacy Martha Q; Gertz Morie A
Excessive fluid accumulation during stem cell mobilization: a novel prognostic factor of first-year survival after stem cell transplantation in AL amyloidosis patients.
Blood 2005;106(10):3353-7.
-
2005: Lacy Martha Q; Hogan William J; Gertz Morie A; Dispenzieri Angela; Rajkumar S Vincent; Hayman Suzanne; Kumar Shaji; Litzow Mark R; Schroeter Arnold L
Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation.
Archives of dermatology 2005;141(10):1277-82.
-
2005: Gertz Morie A; Leung Nelson; Lacy Martha Q; Dispenzieri Angela
Myeloablative chemotherapy and stem cell transplantation in myeloma or primary amyloidosis with renal involvement.
Kidney international 2005;68(4):1464-71.
-
2005: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Greipp Philip R; Litzow Mark R; Henderson Kimberly J; Van Wier Scott A; Ahmann Greg J; Fonseca Rafael
Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy.
Blood 2005;106(8):2837-40.
-
2005: Nowakowski Grzegorz S; Witzig Thomas E; Dingli David; Tracz Michal J; Gertz Morie A; Lacy Martha Q; Lust John A; Dispenzieri Angela; Greipp Philip R; Kyle Robert A; Rajkumar S Vincent
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma.
Blood 2005;106(7):2276-9.
-
2005: Yoong Yinlee; Porrata Luis F; Inwards David J; Ansell Stephen M; Micallef Ivana N M; Litzow Mark R; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Gastineau Dennis A; Tefferi Ayalew; Elliott Michelle; Snow Denis S; Hogan Willian J; Markovic Svetomir N
The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma.
Leukemia & lymphoma 2005;46(9):1287-94.
-
2005: Chng Wee Joo; Van Wier Scott A; Ahmann Gregory J; Winkler Jerry M; Jalal Syed M; Bergsagel Peter Leif; Chesi Marta; Trendle Mike C; Oken Martin M; Blood Emily; Henderson Kim; Santana-Dávila Rafael; Kyle Robert A; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Greipp Philip R; Fonseca Rafael
A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.
Blood 2005;106(6):2156-61.
-
2005: Leung Nelson; Dispenzieri Angela; Fervenza Fernando C; Lacy Martha Q; Villicana Rafael; Cavalcante Joao L; Gertz Morie A
Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;46(2):270-7.
-
2005: Kumar Shaji; Rajkumar S Vincent; Kyle Robert A; Lacy Martha Q; Dispenzieri Angela; Fonseca Rafael; Lust John A; Gertz Morie A; Greipp Philip R; Witzig Thomas E
Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5668-74.
-
2005: Leung Nelson; Griffin Matthew D; Dispenzieri Angela; Haugen Eric N; Gloor James M; Schwab Thomas R; Textor Stephen C; Lacy Martha Q; Litzow Mark R; Cosio Fernando G; Larson Timothy S; Gertz Morie A; Stegall Mark D
Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(7):1660-70.
-
2005: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne
Current status of stem cell transplantation for multiple myeloma.
Current treatment options in oncology 2005;6(3):229-40.
-
2005: Porrata Luis F; Gertz Morie A; Litzow Mark R; Lacy Martha Q; Dispenzieri Angela; Inwards David J; Ansell Stephen M; Micallef Ivanna N M; Gastineau Dennis A; Elliott Michele; Hogan William J; Hayman Suzanne R; Tefferi Ayalew; Markovic Svetomir N
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1210-8.
-
2005: Leung Nelson; Slezak Jeff M; Bergstralh Erik J; Dispenzieri Angela; Lacy Martha Q; Wolf Robert C; Gertz Morie A
Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(1):102-11.
-
2005: Dispenzieri A; Wiseman G A; Lacy M Q; Litzow M R; Anderson P M; Gastineau D A; Tefferi A; Inwards D J; Micallef I N M; Ansell S M; Porrata L; Elliott M A; Lust J A; Greipp P R; Rajkumar S V; Fonseca R; Witzig T E; Erlichman C; Sloan J A; Gertz M A
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(1):118-25.
-
2005: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R
Amyloidosis.
Best practice & research. Clinical haematology 2005;18(4):709-27.
-
2005: Shanafelt Tait D; Novotny Paul; Johnson Mary E; Zhao Xinghua; Steensma David P; Lacy Martha Q; Rubin Joseph; Sloan Jeff
The well-being and personal wellness promotion strategies of medical oncologists in the North Central Cancer Treatment Group.
Oncology 2005;68(1):23-32.
-
2004: Gertz M A; Lacy M Q; Dispenzieri A; Ansell S M; Elliott M A; Gastineau D A; Inwards D J; Micallef I N M; Porrata L F; Tefferi A; Litzow M R
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate.
Bone marrow transplantation 2004;34(12):1025-31.
-
2004: Dispenzieri Angela; Moreno-Aspitia Alvaro; Suarez Guillermo A; Lacy Martha Q; Colon-Otero Gerardo; Tefferi Ayalew; Litzow Mark R; Roy Vivek; Hogan William J; Kyle Robert A; Gertz Morie A
Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature.
Blood 2004;104(10):3400-7.
-
2004: Dispenzieri Angela; Gertz Morie A; Kyle Robert A; Lacy Martha Q; Burritt Mary F; Therneau Terry M; Greipp Philip R; Witzig Thomas E; Lust John A; Rajkumar S Vincent; Fonseca Rafael; Zeldenrust Steven R; McGregor Christopher G A; Jaffe Allan S
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3751-7.
-
2004: Kumar S; Lacy M Q; Dispenzieri A; Rajkumar S V; Fonseca R; Geyer S; Allmer C; Witzig T E; Lust J A; Greipp P R; Kyle R A; Litzow M R; Gertz M A
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma.
Bone marrow transplantation 2004;34(6):485-90.
-
2004: Dispenzieri Angela; Gertz Morie A; Kyle Robert A; Lacy Martha Q; Burritt Mary F; Therneau Terry M; McConnell Joseph P; Litzow Mark R; Gastineau Dennis A; Tefferi Ayalew; Inwards David J; Micallef Ivana N; Ansell Stephen M; Porrata Luis F; Elliott Michelle A; Hogan William J; Rajkumar S Vincent; Fonseca Rafael; Greipp Philip R; Witzig Thomas E; Lust John A; Zeldenrust Steven R; Snow Denise S; Hayman Susan R; McGregor Christopher G A; Jaffe Allan S
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
Blood 2004;104(6):1881-7.
-
2004: Kumar S; Gertz M A; Dispenzieri A; Lacy M Q; Wellik L A; Fonseca R; Lust J A; Witzig T E; Kyle R A; Greipp P R; Rajkumar S V
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.
Bone marrow transplantation 2004;34(3):235-9.
-
2004: Kumar Shaji K; Therneau Terry M; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Rajkumar S Vincent; Fonseca Rafael; Witzig Thomas E; Lust John A; Larson Dirk R; Kyle Robert A; Greipp Philip R
Clinical course of patients with relapsed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2004;79(7):867-74.
-
2004: Kumar S; Lacy M Q; Dispenzieri A; Rajkumar S V; Fonseca R; Geyer S; Allmer C; Witzig T E; Lust J A; Greipp P R; Kyle R A; Litzow M R; Gertz M A
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy.
Bone marrow transplantation 2004;34(2):161-7.
-
2004: Ma Cynthia X; Lacy Martha Q; Rompala John F; Dispenzieri Angela; Rajkumar S Vincent; Greipp Philip R; Fonseca Rafael; Kyle Robert A; Gertz Morie A
Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma.
Blood 2004;104(1):40-2.
-
2004: Porrata L F; Gertz M A; Geyer S M; Litzow M R; Gastineau D A; Moore S B; Pineda A A; Bundy K L; Padley D J; Persky D; Lacy M Q; Dispenzieri A; Snow D S; Markovic S N
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(6):1085-92.
-
2004: Yaqub Sheraz; Moder Kevin G; Lacy Martha Q
Severe, reversible pulmonary hypertension in a patient with monoclonal gammopathy and features of dermatomyositis.
Mayo Clinic proceedings. Mayo Clinic 2004;79(5):687-9.
-
2004: Dispenzieri Angela; Kyle Robert A; Lacy Martha Q; Therneau Terry M; Larson Dirk R; Plevak Matthew F; Rajkumar S Vincent; Fonseca Rafael; Greipp Philip R; Witzig Thomas E; Lust John A; Zeldenrust Steven R; Snow Denise S; Hayman Susan R; Litzow Mark R; Gastineau Dennis A; Tefferi Ayalew; Inwards David J; Micallef Ivana N; Ansell Stephen M; Porrata Luis F; Elliott Michelle A; Gertz Morie A
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study.
Blood 2004;103(10):3960-3.
-
2004: Kumar S; Witzig T E; Dispenzieri A; Lacy M Q; Wellik L E; Fonseca R; Lust J A; Gertz M A; Kyle R A; Greipp P R; Rajkumar S V
Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(3):624-7.
-
2004: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela
Therapy for immunoglobulin light chain amyloidosis: the new and the old.
Blood reviews 2004;18(1):17-37.
-
2003: Dispenzieri Angela; Lacy Martha Q; Rajkumar S Vincent; Geyer Susan M; Witzig Thomas E; Fonseca Rafael; Lust John A; Greipp Philip R; Kyle Robert A; Gertz Morie A
Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2003;10(4):257-61.
-
2003: Fonseca Rafael; Debes-Marun Carina S; Picken Elisa B; Dewald Gordon W; Bryant Sandra C; Winkler Jerry M; Blood Emily; Oken Martin M; Santana-Dávila Rafael; González-Paz Natalia; Kyle Robert A; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Greipp Philip R
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma.
Blood 2003;102(7):2562-7.
-
2003: Kumar S; Chen M G; Gastineau D A; Gertz M A; Inwards D J; Lacy M Q; Tefferi A; Litzow M R
Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(9):1865-70.
-
2003: Ghobrial I M; Dispenzieri A; Bundy K L; Gastineau D A; Rajkumar S V; Therneau T M; Lacy M Q; Witzig T E; Litzow M R; Christensen B R; Hayman S; Pribula C G; Gertz M A
Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.
Bone marrow transplantation 2003;32(6):587-92.
-
2003: Elliott Michelle A; Nichols William L; Plumhoff Elizabeth A; Ansell Stephen M; Dispenzieri Angela; Gastineau Dennis A; Gertz Morie A; Inwards David J; Lacy Martha Q; Micallef Ivana N M; Tefferi Ayalew; Litzow Mark
Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review.
Mayo Clinic proceedings. Mayo Clinic 2003;78(4):421-30.
-
2003: Rajkumar S V; Gertz M A; Lacy M Q; Dispenzieri A; Fonseca R; Geyer S M; Iturria N; Kumar S; Lust J A; Kyle R A; Greipp P R; Witzig T E
Thalidomide as initial therapy for early-stage myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(4):775-9.
-
2003: Dispenzieri Angela; Kyle Robert A; Lacy Martha Q; Rajkumar S Vincent; Therneau Terry M; Larson Dirk R; Greipp Philip R; Witzig Thomas E; Basu Rita; Suarez Guillermo A; Fonseca Rafael; Lust John A; Gertz Morie A
POEMS syndrome: definitions and long-term outcome.
Blood 2003;101(7):2496-506.
-
2003: Kyle Robert A; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela
Localized AL amyloidosis of the colon: an unrecognized entity.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2003;10(1):36-41.
-
2003: Kumar Shaji; Fonseca Rafael; Dispenzieri Angela; Lacy Martha Q; Lust John A; Wellik Linda; Witzig Thomas E; Gertz Morie A; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent
Prognostic value of angiogenesis in solitary bone plasmacytoma.
Blood 2003;101(5):1715-7.
-
2003: Debes-Marun C S; Dewald G W; Bryant S; Picken E; Santana-Dávila R; González-Paz N; Winkler J M; Kyle R A; Gertz M A; Witzig T E; Dispenzieri A; Lacy M Q; Rajkumar S V; Lust J A; Greipp P R; Fonseca R
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(2):427-36.
-
2003: Pardanani Animesh; Witzig Thomas E; Schroeder Georgene; McElroy Edwin A; Fonseca Rafael; Dispenzieri Angela; Lacy Martha Q; Lust John A; Kyle Robert A; Greipp Philip R; Gertz Morie A; Rajkumar S Vincent
Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis.
Blood 2003;101(3):827-30.
-
2003: Kumar Shaji; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Geyer Susan M; Iturria Nancy L; Fonseca Rafael; Hayman Suzanne R; Lust John A; Kyle Robert A; Greipp Philip R; Witzig Thomas E; Rajkumar S Vincent
Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2003;78(1):34-9.
-
2003: Kyle Robert A; Gertz Morie A; Witzig Thomas E; Lust John A; Lacy Martha Q; Dispenzieri Angela; Fonseca Rafael; Rajkumar S Vincent; Offord Janice R; Larson Dirk R; Plevak Matthew E; Therneau Terry M; Greipp Philip R
Review of 1027 patients with newly diagnosed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2003;78(1):21-33.
-
2002: Borson Nancy D; Lacy Martha Q; Wettstein Peter J
Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma.
Blood 2002;100(13):4629-39.
-
2002: Kumar Shaji; Fonseca Rafael; Dispenzieri Angela; Lacy Martha Q; Lust John A; Witzig Thomas E; Gertz Morie A; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent
Bone marrow angiogenesis in multiple myeloma: effect of therapy.
British journal of haematology 2002;119(3):665-71.
-
2002: Litzow Mark R; Repoussis Panagiotis D; Schroeder Georgene; Schembri-Wismayer David; Batts Kenneth P; Anderson Peter M; Arndt Carola A S; Chen Michael G; Gastineau Dennis A; Gertz Morie A; Inwards David J; Lacy Martha Q; Tefferi Ayalew; Noël Pierre; Solberg Lawrence A; Letendre Louis; Hoagland H Clark
Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator.
Leukemia & lymphoma 2002;43(11):2099-107.
-
2002: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Gastineau Dennis A; Chen Michael G; Ansell Stephen M; Inwards David J; Micallef Ivana N M; Tefferi Ayalew; Litzow Mark R
Stem cell transplantation for the management of primary systemic amyloidosis.
The American journal of medicine 2002;113(7):549-55.
-
2002: Rajkumar S Vincent; Hayman Suzanne; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Greipp Philip R; Geyer Susan; Iturria Nancy; Fonseca Rafael; Lust John A; Kyle Robert A; Witzig Thomas E
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4319-23.
-
2002: Kumar S; Wolf R C; Chen M G; Gastineau D A; Gertz M A; Inwards D J; Lacy M Q; Tefferi A; Litzow M R
Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease.
Bone marrow transplantation 2002;30(3):161-5.
-
2002: Rajkumar S Vincent; Mesa Ruben A; Fonseca Rafael; Schroeder Georgene; Plevak Matthew F; Dispenzieri Angela; Lacy Martha Q; Lust John A; Witzig Thomas E; Gertz Morie A; Kyle Robert A; Russell Stephen J; Greipp Philip R
Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2210-6.
-
2002: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Cheson Bruce D; Barlogie Bart; Kyle Robert A; Palladini Giovanni; Geyer Susan M; Merlini Giampaolo
A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL).
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2002;9(1):24-30.
-
2002: Donovan K A; Lacy M Q; Gertz M A; Lust J A
IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(3):382-5.
-
2002: Schop Roelandt F J; Jalal Syed M; Van Wier Scott A; Ahmann Gregory J; Bailey Richard J; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent; Gertz Morie A; Lust John A; Lacy Martha Q; Dispenzieri Angela; Witzig Thomas E; Fonseca Rafael
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression.
Cancer genetics and cytogenetics 2002;132(1):55-60.
-
2002: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela
Immunoglobulin light chain amyloidosis and the kidney.
Kidney international 2002;61(1):1-9.
-
2001: Rajkumar S V; Fonseca R; Dispenzieri A; Lacy M Q; Lust J A; Witzig T E; Therneau T M; Kyle R A; Greipp P R; Gertz M A
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantation.
American journal of hematology 2001;68(4):269-75.
-
2001: Tefferi A; Kumar S; Wolf R C; Lacy M Q; Inwards D J; Gloor J M; Albright R C; Kamath P S; Litzow M R
Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
Bone marrow transplantation 2001;28(10):997-9.
-
2001: Kumar S; Chen M G; Gastineau D A; Gertz M A; Inwards D J; Lacy M Q; Tefferi A; Litzow M R
Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia.
Bone marrow transplantation 2001;28(10):951-6.
-
2001: Hayman S R; Lacy M Q; Kyle R A; Gertz M A
Primary systemic amyloidosis: a cause of malabsorption syndrome.
The American journal of medicine 2001;111(7):535-40.
-
2001: Porrata L F; Inwards D J; Lacy M Q; Markovic S N
Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
Bone marrow transplantation 2001;28(7):673-80.
-
2001: Hayman S R; Bailey R J; Jalal S M; Ahmann G J; Dispenzieri A; Gertz M A; Greipp P R; Kyle R A; Lacy M Q; Rajkumar S V; Witzig T E; Lust J A; Fonseca R
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis.
Blood 2001;98(7):2266-8.
-
2001: Kumar S; Dispenzieri A; Lacy M Q; Litzow M R; Gertz M A
High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis.
Bone marrow transplantation 2001;28(4):381-5.
-
2001: Hogan W J; Lacy M Q; Wiseman G A; Fealey R D; Dispenzieri A; Gertz M A
Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation.
Bone marrow transplantation 2001;28(3):305-9.
-
2001: Rajkumar S V; Dispenzieri A; Fonseca R; Lacy M Q; Geyer S; Lust J A; Kyle R A; Greipp P R; Gertz M A; Witzig T E
Thalidomide for previously untreated indolent or smoldering multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(8):1274-6.
-
2001: Porrata L F; Gertz M A; Inwards D J; Litzow M R; Lacy M Q; Tefferi A; Gastineau D A; Dispenzieri A; Ansell S M; Micallef I N; Geyer S M; Markovic S N
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma.
Blood 2001;98(3):579-85.
-
2001: Dispenzieri A; Lacy M Q; Kyle R A; Therneau T M; Larson D R; Rajkumar S V; Fonseca R; Greipp P R; Witzig T E; Lust J A; Gertz M A
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3350-6.
-
2001: Kumar S; Chen M G; Gastineau D A; Gertz M A; Inwards D J; Lacy M Q; Tefferi A; Harmsen W S; Litzow M R
Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease.
Bone marrow transplantation 2001;27(11):1133-40.
-
2001: Steensma D P; Gertz M A; Greipp P R; Kyle R A; Lacy M Q; Lust J A; Offord J R; Plevak M F; Therneau T M; Witzig T E
A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death.
Blood 2001;97(8):2522-3.
-
2000: Rajkumar S V; Fonseca R; Dispenzieri A; Lacy M Q; Witzig T E; Lust J A; Larson D; Therneau T M; Kyle R A; Litzow M R; Greipp P R; Gertz M A
Effect of complete response on outcome following autologous stem cell transplantation for myeloma.
Bone marrow transplantation 2000;26(9):979-83.
-
2000: Gertz M A; Lacy M Q; Gastineau D A; Inwards D J; Chen M G; Tefferi A; Kyle R A; Litzow M R
Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL).
Bone marrow transplantation 2000;26(9):963-9.
-
2000: Rajkumar S V; Fonseca R; Dispenzieri A; Lacy M Q; Lust J A; Witzig T E; Kyle R A; Gertz M A; Greipp P R
Thalidomide in the treatment of relapsed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2000;75(9):897-901.
-
2000: Rajkumar S V; Leong T; Roche P C; Fonseca R; Dispenzieri A; Lacy M Q; Lust J A; Witzig T E; Kyle R A; Gertz M A; Greipp P R
Prognostic value of bone marrow angiogenesis in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3111-6.
-
2000: Gertz M A; Lacy M Q; Inwards D J; Gastineau D A; Tefferi A; Chen M G; Witzig T E; Greipp P R; Litzow M R
Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma.
Bone marrow transplantation 2000;26(1):45-50.
-
2000: Kyle R A; Greipp P R; Gertz M A; Witzig T E; Lust J A; Lacy M Q; Therneau T M
Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil.
British journal of haematology 2000;108(4):737-42.
-
2000: Gertz M A; Lacy M Q; Dispenzieri A
Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report.
Bone marrow transplantation 2000;25(5):465-70.
-
1999: Lacy M Q; Gertz M A
Acquired Fanconi's syndrome associated with monoclonal gammopathies.
Hematology/oncology clinics of North America 1999;13(6):1273-80.
-
1999: Gertz M A; Lacy M Q; Dispenzieri A
Amyloidosis.
Hematology/oncology clinics of North America 1999;13(6):1211-33, ix.
-
1999: Fonseca R; Hoyer J D; Aguayo P; Jalal S M; Ahmann G J; Rajkumar S V; Witzig T E; Lacy M Q; Dispenzieri A; Gertz M A; Kyle R A; Greipp P R
Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.
Leukemia & lymphoma 1999;35(5-6):599-605.
-
1999: Rajkumar S V; Fonseca R; Dewald G W; Therneau T M; Lacy M Q; Kyle R A; Greipp P R; Gertz M A
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.
Cancer genetics and cytogenetics 1999;113(1):73-7.
-
1999: Gertz M A; Lacy M Q; Lust J A; Greipp P R; Witzig T E; Kyle R A
Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis.
Medical oncology (Northwood, London, England) 1999;16(2):104-9.
-
1999: Rajkumar S V; Fonseca R; Lacy M Q; Witzig T E; Lust J A; Greipp P R; Therneau T M; Kyle R A; Litzow M R; Gertz M A
Autologous stem cell transplantation for relapsed and primary refractory myeloma.
Bone marrow transplantation 1999;23(12):1267-72.
-
1999: Rajkumar S V; Fonseca R; Lacy M Q; Witzig T E; Lust J A; Greipp P R; Therneau T M; Kyle R A; Litzow M R; Gertz M A
Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma.
Bone marrow transplantation 1999;23(12):1261-6.
-
1999: Gertz M A; Lacy M Q; Lust J A; Greipp P R; Witzig T E; Kyle R A
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis.
American journal of hematology 1999;61(2):115-9.
-
1999: Rajkumar S V; Fonseca R; Lacy M Q; Witzig T E; Therneau T M; Kyle R A; Litzow M R; Gertz M A; Greipp P R
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1551-7.
-
1999: Gertz M A; Lacy M Q; Dispenzieri A
Amyloidosis: recognition, confirmation, prognosis, and therapy.
Mayo Clinic proceedings. Mayo Clinic 1999;74(5):490-4.
-
1999: Gertz M A; Lacy M Q; Inwards D J; Chen M G; Pineda A A; Gastineau D A; Greipp P R; Lust J A; Tefferi A; Witzig T E; Kyle R A; Litzow M R
Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
Bone marrow transplantation 1999;23(3):221-6.
-
1999: Kyle R A; Gertz M A; Greipp P R; Witzig T E; Lust J A; Lacy M Q; Therneau T M
Long-term survival (10 years or more) in 30 patients with primary amyloidosis.
Blood 1999;93(3):1062-6.
-
1999: Gertz M A; Lacy M Q; Lust J A; Greipp P R; Witzig T E; Kyle R A
Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):262-7.
-
1999: Lacy M Q; Donovan K A; Heimbach J K; Ahmann G J; Lust J A
Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma.
Blood 1999;93(1):300-5.
-
1998: Donovan K A; Lacy M Q; Kline M P; Ahmann G J; Heimbach J K; Kyle R A; Lust J A
Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(4):593-600.
-
1998: Palmas A; Tefferi A; Myers J L; Scott J P; Swensen S J; Chen M G; Gastineau D A; Gertz M A; Inwards D J; Lacy M Q; Litzow M R
Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation.
British journal of haematology 1998;100(4):680-7.
-
1997: Lacy M Q; Gertz M A; Hanson C A; Inwards D J; Kyle R A
Multiple myeloma associated with diffuse osteosclerotic bone lesions: a clinical entity distinct from osteosclerotic myeloma (POEMS syndrome).
American journal of hematology 1997;56(4):288-93.
-
1997: Elliott M A; Tefferi A; Marshall W F; Lacy M Q
Disseminated nocardiosis after allogeneic bone marrow transplantation.
Bone marrow transplantation 1997;20(5):425-6.
-
1997: Gertz M A; Lacy M Q; Inwards D J; Pineda A A; Chen M G; Gastineau D A; Tefferi A; Kyle R A; Litzow M R
Factors influencing platelet recovery after blood cell transplantation in multiple myeloma.
Bone marrow transplantation 1997;20(5):375-80.
-
1997: Kyle R A; Gertz M A; Greipp P R; Witzig T E; Lust J A; Lacy M Q; Therneau T M
A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.
The New England journal of medicine 1997;336(17):1202-7.
-
1996: Lacy M Q; Kurtin P J; Tefferi A
Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities.
Blood 1996;87(7):3000-6.
Sign-in to see more
